Table 2.
Laboratory findings and radiographic results for patients with adenovirus-associated ARDS.
| Characteristic | Adenovirus associated ARDS (n = 14) | Non-adenovirus associated ARDS (n = 33) | P-value |
|---|---|---|---|
| White blood cell count, × 109/L | 12.66 ± 6.40 | 11.95 ± 6.67 | 0.84 |
| <4 | 0 | 3(9.09%) | 0.24 |
| >10 | 9(64.29%) | 14(42.42%) | 0.17 |
| Platelet count, × 109/L | 165.43 ± 103.26 | 168.24 ± 75.45 | 0.92 |
| <100 | 5(35.71%) | 6(18.18%) | 0.36 |
| Lymphocyte, × 109/L | 0.64 ± 0.49 | 0.54 ± 0.24 | 0.59 |
| <0.9 | 10(71.43%) | 28(84.80%) | 0.51 |
| CD3+CD45+ T, Cell/Ul | 278.00(171.50-634.00) | 343.00(138.00-665.00) | 0.67 |
| <955 | 12(85.71%) | 24(72.73%) | 0.56 |
| CD3+CD4+ T, Cell/Ul | 148.00(106.00-365.00) | 237.00(101.00-596.00) | 0.08 |
| <550 | 12(85.71%) | 18(54.55%) | 0.041 |
| CD3+CD8+ T, Cell/Ul | 120.00(57.50-282.00) | 107.00(62.00-259.00) | 0.91 |
| <320 | 11(78.57%) | 22(66.66%) | 0.64 |
| Interleukin-6, pg/ml | 39.37(12.53-143.06) | 22.93(12.40-140.14) | 0.84 |
| >5.3 | 12(85.71%) | 22(66.66%) | 0.33 |
| Procalcitonin, ng/ml | 0.38(1.90-4.66) | 0.29(1.69-5.43) | 0.98 |
| Arterial blood gas analysis: | |||
| pH | 7.37 ± 0.09 | 7.37 ± 0.12 | 0.90 |
| pCO2, mmHg | 44.12 ± 6.83 | 47.09 ± 10.26 | 0.33 |
| P/F | 168.59 ± 41.77 | 153.13 ± 53.77 | 0.34 |
| <150 | 5(35.71%) | 20(60.61.%) | 0.12 |
| 150-200 | 9(64.29%) | 8(24.24%) | 0.01 |
| Albumin, g/L | 30.96 ± 10.14 | 31.21 ± 6.89 | 0.92 |
| <35 | 12(85.71%) | 28(84.85%) | >0.99 |
| Prothrombin time, s | 16.06 ± 2.73 | 16.24 ± 2.15 | 0.80 |
| >14.5 | 10(71.43%) | 29(87.88.%) | 0.34 |
| Activated partial thromboplastin time, s | 51.23 ± 28.21 | 48.98 ± 20.04 | 0.76 |
| >42.8 | 9(64.29%) | 16(48.48%) | 0.32 |
| Creatinine, umol/L | 162.55(87.50-282.50) | 73.0(60.0-117.30) | 0.047 |
| >133 | 9(64.29%) | 7(21.21%) | 0.01 |
| Abnormalities on chest radiograph | |||
| Ground-glass opacity | 2(14.29%) | 1(3.03%) | 0.43 |
| Bilateral patchy shadowing | 14(100%) | 29(87.88%) | 0.17 |
| Interstitial abnormalities | 3(21.43%) | 4(12.12%) | 0.71 |
| Pleural effusions | 5(35.71%) | 6(18.18%) | 0.36 |